{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T21:58:56Z","timestamp":1762898336594,"version":"3.44.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.metabol.2007.08.015","type":"journal-article","created":{"date-parts":[[2007,12,17]],"date-time":"2007-12-17T13:58:03Z","timestamp":1197899883000},"page":"121-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone\u2013deficient adults"],"prefix":"10.1016","volume":"57","author":[{"given":"Maria Claudia Peixoto","family":"Cenci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via L\u00facia","family":"Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora Vieira","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Diniz Carneiro","family":"Spina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosane Resende de Lima Oliveira","family":"Brasil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila Marise","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Michmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Vaisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2007.08.015_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.1999.00682.x","article-title":"Cardiovascular disease and risk factors in adults with hypopituitarism","volume":"50","author":"Beshyah","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.metabol.2007.08.015_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2265.1992.tb02347.x","article-title":"The growth hormone deficiency syndrome in adults","volume":"37","author":"Cuneo","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.metabol.2007.08.015_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0950-351X(98)80018-9","article-title":"Growth hormone deficiency and cardiovascular risk","volume":"12","author":"Hew","year":"1998","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib4","first-page":"195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency","volume":"129","author":"Ros\u00e9n","year":"1993","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.metabol.2007.08.015_bib5","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/0140-6736(92)92892-J","article-title":"Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults","volume":"340","author":"Markussis","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2007.08.015_bib6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/0026-0495(95)90004-7","article-title":"Growth hormone deficient adults are insulin-resistant","volume":"44","author":"Johansson","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2007.08.015_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.14.3.434","article-title":"High fibrinogen and plasminogen activator inhibitor activity in growth hormone\u2013deficient adults","volume":"14","author":"Johansson","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.metabol.2007.08.015_bib8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/jappl.1991.70.2.695","article-title":"Growth hormone treatment in growth hormone deficient adults. II. Effects on exercise performance","volume":"70","author":"Cuneo","year":"1991","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.metabol.2007.08.015_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/frne.2001.0215","article-title":"Growth hormone therapy in adults","volume":"22","author":"Concei\u00e7\u00e3o","year":"2001","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.metabol.2007.08.015_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism","volume":"46","author":"B\u00fclow","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.metabol.2007.08.015_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Ros\u00e9n","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2007.08.015_bib12","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","article-title":"The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients","volume":"84","author":"Gibney","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib13","first-page":"108","article-title":"The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults","volume":"83","author":"Cuneo","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib14","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","article-title":"A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass and metabolic indices","volume":"86","author":"G\u00f6therstr\u00f6m","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib15","first-page":"153","article-title":"The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults","volume":"80","author":"Weaver","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2265.1998.00460.x","article-title":"Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults","volume":"48","author":"Al-Shoumer","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.metabol.2007.08.015_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ghir.2003.08.002","article-title":"Glucose metabolism and visceral fat in GH deficient adults: 1 year of GH replacement","volume":"14","author":"Spina","year":"2004","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.metabol.2007.08.015_bib18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0038-1650594","article-title":"Long-term treatment with growth hormone decreases plasminogen activator inhibitor\u20131 and tissue plasminogen activator in growth hormone\u2013deficient adults","volume":"76","author":"Johansson","year":"1996","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.metabol.2007.08.015_bib19","first-page":"3285","article-title":"Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience","volume":"82","author":"Hwu","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib20","first-page":"356","article-title":"The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance","volume":"80","author":"Beshyah","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib21","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1210\/jcem.85.11.6930","article-title":"The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults","volume":"85","author":"Rosenfalck","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1054\/ghir.1999.0091","article-title":"The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone\u2013deficient adults following 4-month growth hormone replacement therapy","volume":"9","author":"Rosenfalck","year":"1999","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.metabol.2007.08.015_bib23","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1210\/jcem.87.5.8482","article-title":"Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults","volume":"87","author":"Svensson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib24","first-page":"1668","article-title":"Defects of insulin action and skeletal muscle glucose metabolism in growth hormone\u2013deficient adults persist after 24 months of recombinant human growth hormone therapy","volume":"83","author":"Christopher","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2265.1999.00595.x","article-title":"A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance","volume":"50","author":"Bulow","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.metabol.2007.08.015_bib26","first-page":"3762","article-title":"Effects of 7 years of growth hormone replacement therapy in hypopituitary adults","volume":"85","author":"Chrisoulidou","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib27","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2007.08.015_bib28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Mathews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2007.08.015_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.metabol.2004.09.011","article-title":"Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement","volume":"54","author":"Soares","year":"2005","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.metabol.2007.08.015_bib30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2007.08.015_bib31","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth-hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials","volume":"89","author":"Maison","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/bmj.322.7288.716","article-title":"Treatment of obesity: need to focus on high risk abdominally obese patients","volume":"322","author":"Despres","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2007.08.015_bib33","first-page":"309","article-title":"Treatment of adults with growth hormone (GH) deficiency with recombinant human GH","volume":"76","author":"Bengtsson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-005-5065-6","article-title":"Glucose metabolism and visceral fat in GH deficient adults: two years of GH-replacement","volume":"7","author":"Spina","year":"2004","journal-title":"Pituitary"},{"key":"10.1016\/j.metabol.2007.08.015_bib35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/diab.31.8.663","article-title":"Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization","volume":"31","author":"Rizza","year":"1982","journal-title":"Diabetes"},{"issue":"Suppl 3","key":"10.1016\/j.metabol.2007.08.015_bib36","first-page":"45","article-title":"Insulin sensitivity in adults with growth hormone deficiency and effect of growth hormone treatment","volume":"64","author":"Groop","year":"2005","journal-title":"Horm Res"},{"key":"10.1016\/j.metabol.2007.08.015_bib37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1301\/nr.2003.dec.397-412","article-title":"Evaluation of insulin sensitivity in clinical practice and in research settings","volume":"61","author":"Monzillo","year":"2003","journal-title":"Nutr Rev"},{"key":"10.1016\/j.metabol.2007.08.015_bib38","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1210\/jc.2005-2227","article-title":"Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline","volume":"91","author":"Molitch","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2265.2005.02359.x","article-title":"Improvements in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone dose in adults with severe GH deficiency","volume":"63","author":"Yuen","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.metabol.2007.08.015_bib40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2265.1997.3271123.x","article-title":"Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults","volume":"47","author":"Johannsson","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.metabol.2007.08.015_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.1.01817","article-title":"One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults","volume":"152","author":"Boguszewski","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2007.08.015_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ghir.2006.03.007","article-title":"Growth hormone dosing variables in growth hormone\u2013deficient adults","volume":"16","author":"Cook","year":"2006","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.metabol.2007.08.015_bib43","first-page":"453","article-title":"Growth (GH) hormone treatment reverses early atherosclerotic changes in GH-deficient adults","volume":"84","author":"Pfeifer","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib44","first-page":"1329","article-title":"Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency","volume":"84","author":"Borson-Chazot","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib45","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1210\/jc.2004-2247","article-title":"Short-term effect of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency","volume":"90","author":"Colao","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199901073400103","article-title":"Carotid-artery intima media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group","volume":"340","author":"O'Leary","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2007.08.015_bib47","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1073\/pnas.89.15.6983","article-title":"Importance of growth hormone for the induction of hepatic low density lipoprotein receptors","volume":"89","author":"Rudling","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2007.08.015_bib48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1043-2760(98)00050-2","article-title":"Dyslipidaemia in adult growth hormone (GH) deficiency and the effect of GH replacement therapy: a review","volume":"9","author":"Christ","year":"1998","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib49","first-page":"1600","article-title":"Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status\u20143-year results from the HypoCCS Database","volume":"87","author":"Attanasio","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1054\/ghir.1999.0102","article-title":"The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo[a] in hypopituitary adults previously treated with conventional replacement therapy","volume":"9","author":"O'Neal","year":"1999","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.metabol.2007.08.015_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.0.1340061","article-title":"An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adults acquired growth hormone deficiency","volume":"134","author":"Garry","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2007.08.015_bib52","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1515\/CCLM.2001.068","article-title":"The Friedewald formula underestimates LDL cholesterol at low concentrations","volume":"39","author":"Scharnagl","year":"2001","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.metabol.2007.08.015_bib53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2796.2003.01276.x","article-title":"Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy","volume":"255","author":"Walldius","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2007.08.015_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0021-9150(97)00110-X","article-title":"The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein (a) in growth hormone\u2013deficient adults","volume":"133","author":"Webster","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2007.08.015_bib55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency: a randomized, controlled clinical trial","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2007.08.015_bib56","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1161\/01.ATV.15.12.2142","article-title":"Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone\u2013deficient adults. Influence of gender and apo(a) and apoE phenotypes","volume":"15","author":"Johannsson","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2007.08.015_bib57","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0026-0495(93)90145-E","article-title":"Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency","volume":"42","author":"Cuneo","year":"1993","journal-title":"Metabolism"},{"issue":"Suppl\u00a0A","key":"10.1016\/j.metabol.2007.08.015_bib58","first-page":"31","article-title":"Modification of blood lipids and lipoproteins after human growth hormone treatment in adults with growth hormone deficiency: a preliminary report","volume":"1","author":"Modigliani","year":"1994","journal-title":"Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.08.015_bib59","doi-asserted-by":"crossref","first-page":"15657","DOI":"10.1016\/S0021-9258(19)49586-0","article-title":"Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. A function of the ability of apolipoprotein B to direct lipoprotein assembly and escape presecretory degradation","volume":"267","author":"White","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2007.08.015_bib60","doi-asserted-by":"crossref","first-page":"19362","DOI":"10.1074\/jbc.M400220200","article-title":"Regulation of hepatic apolipoprotein B\u2013lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles","volume":"279","author":"Zhang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2007.08.015_bib61","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/01.CIR.73.5.978","article-title":"Plasma apoproteins and the severity of coronary artery disease","volume":"73","author":"Sedlis","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2007.08.015_bib62","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)12663-3","article-title":"Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment","volume":"361","author":"Sniderman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2007.08.015_bib63","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2796.2006.01644.x","article-title":"Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B\/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies","volume":"259","author":"Thompson","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2007.08.015_bib64","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2796.2005.01610.x","article-title":"Stroke mortality and the apoB\/apoA-I ratio: results of the AMORIS prospective study","volume":"259","author":"Walldius","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2007.08.015_bib65","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.amjcard.2006.06.029","article-title":"Comparison of apolipoprotein-B\/apolipoprotein-AI in subjects with versus without the metabolic syndrome","volume":"98","author":"Sierra-Johnson","year":"2006","journal-title":"Am J Cardiol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049507003113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049507003113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:25:37Z","timestamp":1758425137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049507003113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0026049507003113"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2007.08.015","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone\u2013deficient adults","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2007.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}